查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363519

噴射霧化器市場規模、佔有率、趨勢分析報告：按適應症、最終用途、地區、細分市場趨勢，2023-2030 年

Pneumatic Nebulizers Market Size, Share & Trends Analysis Report By Indication (Breath-actuated, Vented), By End-use (Hospitals & Clinics, Home Healthcare), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

噴射霧化器市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球噴射霧化器市場規模將達11.667億美元，2023年至2030年年複合成長率為6.3%。

近年來，由於家庭醫療保健設備的普及，市場上噴射霧化器的採用量穩定增加。產品小型化和技術進步也推動了家庭醫療保健設備的採用。

據明尼蘇達州衛生署稱，與其他產生氣溶膠的手術相比，給藥霧化器給藥的感染風險較低。另一方面，根據 ISAM 的說法，霧化器產生的氣溶膠不攜帶源自患者的病毒顆粒，因為它們是由霧化器室內的液體產生的。只有當醫護人員或病患污染了霧化器時，霧化器產生的氣溶膠才含有病原體。關於大流行期間是否適合使用霧化器，各機構的各種建議仍不清楚。

然而，尚無已知的霧化器被動感染案例。即使有感染風險，也可以透過採取適當的 COVID-19 預防措施來避免。因此，疫情對整個市場僅產生了一定的影響。革命性的技術進步正在迅速改變市場。這種擴張正在創造利潤豐厚的可能性。例如，2019年3月，Breath Technologies宣布啟動L-CSA-i的3期波士頓臨床試驗，透過PARI Pharma的在研藥物特異性eFlow霧化器治療阻塞性細支氣管炎症候群。

噴射霧化器市場報告亮點：

  • 由於產品需求增加，呼吸驅動產品細分市場在 2022 年將佔據超過 64.2% 的主導收益佔有率。
  • 由於醫院和診所的產品使用量較高，醫院和診所最終用途細分市場在 2022 年佔據市場主導地位，收益佔有率超過 65%。
  • 由於呼吸道疾病患病不斷上升以及產品採用率較高，2022 年北美地區的收益佔有率最大，超過 35.54%。
  • 由於中國和印度等新興經濟體的存在，亞太地區預計將成為成長最快的地區，在預測期內年複合成長率為 7.4%。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 噴射霧化器市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 噴射霧化器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 噴射霧化器：根據指示進行估算和估算/趨勢分析

  • 噴射霧化器市場：重點
  • 噴射霧化器市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 吸氣同步
  • 通風型

第5章 噴射霧化器：依最終用途的估算與趨勢分析

  • 噴射霧化器市場：重點
  • 噴射霧化器市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院和診所
  • 家庭保健

第6章 噴射霧化器：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的噴射霧化器市場：重點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Koninklijke Philips NV
    • OMRON Corporation
    • PARI GmbH
    • General Electric
    • Allied Healthcare Products, Inc.
    • BD (Becton, Dickinson and Company)
    • GF Health Products, Inc.
    • Medline Industries, LP
    • Briggs Healthcare
    • Vectura Group Ltd
Product Code: GVR-1-68038-194-8

Pneumatic Nebulizers Market Growth & Trends:

The global pneumatic nebulizers market size is expected to reach USD 1,166.7 million by 2030, registering a CAGR of 6.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market has shown constant growth in the adoption of pneumatic nebulizers as home healthcare devices have been gaining popularity in recent years. Miniaturization of products and technological advancements are also boosting the adoption of home healthcare devices.

As per the Minnesota Department of Health, administration of medication through nebulizer represents a lower infection risk as compared to other aerosol-producing procedures. On the other hand, according to ISAM, aerosols from the nebulizer do not carry viral particles derived from the patient as they are generated from the fluid in the nebulized chamber, which is a non-patient source. Aerosols generated by nebulizers comprise pathogens only when the healthcare workers or patients contaminate the nebulizers. Various recommendations from institutes do not clarify whether it is appropriate to use nebulizers during the pandemic.

However, there are no known cases of passive infection due to nebulizers. Also, the risk of infection, if any, can be avoided if proper COVID-19 precautions are taken. Therefore, the pandemic affected the overall market only to a certain extent. Revolutionary technological progress is rapidly transforming the market. These expansions are producing lucrative potentials. For instance, in March 2019, Breath Technologies announced the initiation of Phase 3 BOSTON clinical study of L-CsA-i for the treatment of bronchiolitis obliterans syndrome via a drug-specific eFlow nebulizer of PARI Pharma that is under investigation.

Pneumatic Nebulizers Market Report Highlights:

  • The breath-actuated product segment held the dominant revenue share of over 64.2% in 2022 owing to the increased product demand
  • The hospitals & clinics end-use segment dominated the market in 2022 with a revenue share of more than 65% owing to the high product usage a hospitals & clinics
  • North America accounted for the largest revenue share of more than 35.54% in 2022 owing to the increased prevalence of respiratory diseases and high product adoption
  • Asia Pacific is expected to be the fastest-growing region, with a CAGR of 7.4% over the forecast period owing to the presence of emerging countries, such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Indication
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Indication outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pneumatic Nebulizers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
    • 3.4.2. Market restraint analysis
  • 3.5. Pneumatic Nebulizers Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Pneumatic Nebulizers: Indication Estimates & Trend Analysis

  • 4.1. Pneumatic Nebulizers Market: Key Takeaways
  • 4.2. Pneumatic Nebulizers Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Breath-Actuated
    • 4.3.1. Breath-Actuated market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Vented
    • 4.4.1. Vented market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Pneumatic Nebulizers: End use Estimates & Trend Analysis

  • 5.1. Pneumatic Nebulizers Market: Key Takeaways
  • 5.2. Pneumatic Nebulizers Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals & Clinics
    • 5.3.1. Hospitals & Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Home Healthcare
    • 5.4.1. Home Healthcare market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Pneumatic Nebulizers: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Pneumatic Nebulizers Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Koninklijke Philips N.V.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. OMRON Corporation
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. PARI GmbH
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. General Electric
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Allied Healthcare Products, Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. BD (Becton, Dickinson and Company)
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. GF Health Products, Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Medline Industries, LP
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Briggs Healthcare
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Vectura Group Ltd
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 3 North America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 6 U.S. pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 8 Canada pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 10 Europe pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 12 UK pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 13 UK pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Germany pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 17 France pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 19 Italy pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 21 Spain pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Denmark pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Denmark pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Sweden pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 25 Sweden pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 27 Norway pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 32 Japan pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 34 China pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 36 India pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 38 Australia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 40 Thailand pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 42 South Korea pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 44 Latin America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 47 Brazil pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 49 Mexico pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 51 Argentina pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa pneumatic nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 56 South Africa pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 60 UAE pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Kuwait pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Pneumatic nebulizers: Market outlook
  • Fig. 8 Pneumatic nebulizers: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Pneumatic nebulizers market driver impact
  • Fig. 13 Pneumatic nebulizers market restraint impact
  • Fig. 14 Pneumatic nebulizers market strategic initiatives analysis
  • Fig. 15 Pneumatic nebulizers market: Indication movement analysis
  • Fig. 16 Pneumatic nebulizers market: Indication outlook and key takeaways
  • Fig. 17 Breath-actuated market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Vented market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Pneumatic nebulizers market: End use movement analysis
  • Fig. 20 Pneumatic nebulizers market: End use outlook and key takeaways
  • Fig. 21 Hospital and clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Home healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global pneumatic nebulizers market: Regional movement analysis
  • Fig. 24 Global pneumatic nebulizers market: Regional outlook and key takeaways
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)